4-cyano-N-(4-(5,6,7-trimethoxy-4-oxo-4H-chromen-2-yl)phenyl)benzamide

ID: ALA5269618

Max Phase: Preclinical

Molecular Formula: C26H20N2O6

Molecular Weight: 456.45

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1cc2oc(-c3ccc(NC(=O)c4ccc(C#N)cc4)cc3)cc(=O)c2c(OC)c1OC

Standard InChI:  InChI=1S/C26H20N2O6/c1-31-22-13-21-23(25(33-3)24(22)32-2)19(29)12-20(34-21)16-8-10-18(11-9-16)28-26(30)17-6-4-15(14-27)5-7-17/h4-13H,1-3H3,(H,28,30)

Standard InChI Key:  OYXNRGWJLJUPBB-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 34 37  0  0  0  0  0  0  0  0999 V2000
   -4.2843   -0.4106    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5697    0.0016    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8577   -0.4102    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8577   -1.2354    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5679   -1.6472    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2843   -1.2391    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9989   -1.6517    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7135   -1.2391    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1400   -1.6495    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4284   -1.2328    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4302   -0.4118    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1450    0.0006    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7155    0.0007    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7152    0.8259    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0024    1.2366    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7124    0.8239    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7139    0.0028    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0021   -0.4136    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4270    1.2365    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.1416    0.8239    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8563    1.2365    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8565    2.0618    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5693    2.4725    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2842    2.0598    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2858    1.2387    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5739    0.8222    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1416   -0.0011    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1400   -2.4747    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9989    0.0019    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9989    0.8271    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5679   -2.4723    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2824   -2.8849    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9989    2.4723    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7135    2.8849    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  1  0
  4  3  2  0
  5  4  1  0
  6  5  2  0
  1  6  1  0
  6  7  1  0
  7  8  1  0
  4  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
  3 12  1  0
 13 11  1  0
 14 13  2  0
 15 14  1  0
 16 15  2  0
 17 16  1  0
 18 17  2  0
 13 18  1  0
 16 19  1  0
 19 20  1  0
 20 21  1  0
 22 21  2  0
 23 22  1  0
 24 23  2  0
 25 24  1  0
 26 25  2  0
 21 26  1  0
 20 27  2  0
  9 28  2  0
  1 29  1  0
 29 30  1  0
  5 31  1  0
 31 32  1  0
 33 24  1  0
 33 34  3  0
M  END

Alternative Forms

  1. Parent:

    ALA5269618

    ---

Associated Targets(Human)

EKVX (44102 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HOP-92 (41141 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H226 (44470 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H23 (49055 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H522 (44358 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SF-295 (48000 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
UO-31 (46270 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hs-578T (29457 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 456.45Molecular Weight (Monoisotopic): 456.1321AlogP: 4.61#Rotatable Bonds: 6
Polar Surface Area: 110.79Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 3.44CX LogD: 3.44
Aromatic Rings: 4Heavy Atoms: 34QED Weighted: 0.45Np Likeness Score: -0.21

References

1. Hassan AHE, Lee KT, Lee YS..  (2020)  Flavone-based arylamides as potential anticancers: Design, synthesis and in vitro cell-based/cell-free evaluations.,  187  [PMID:31877541] [10.1016/j.ejmech.2019.111965]

Source